Literature DB >> 8554981

Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.

A Heagerty1, A Smith, J English, J Lear, W Perkins, B Bowers, P Jones, J Gilford, J Alldersea, A Fryer, R C Strange.   

Abstract

The factors that determine development of single and multiple primary cutaneous basal cell carcinomas (BCCs) are unclear. We describe a case-control study firstly, to examine the influence of allelism at the glutathione S-transferase GSTM1 and GSTT1 and cytochrome P450 CYP2D6 loci on susceptibility to these tumours and, secondly, to identify interactions between genotypes and relevant individual characteristics, such as skin type and gender. Frequency distributions for GSTM1 genotypes in cases and controls were not different, although the frequency of GSTM1 A/B was significantly lower (P = 0.048) in the multiple BCCs than in controls. We found no significant differences in the frequencies of GSTT1 and CYP2D6 genotypes in cases and controls. Interactions between genotypes were studied by comparing multinomial frequency distributions in mutually exclusive groups. These identified no differences between cases and controls for combinations of the putatively high risk GSTM1 null, GSTT1 null, CYP2D6 EM genotypes. Interactions between GSTM1 A/B and the CYP2D6 PM and GSTT1-positive genotypes were also not different. Frequency distributions of GSTM1 A/B with CYP2D6 EM in controls and multiple BCCs were significantly different (P = 0.033). The proportion of males in the multiple BCC group (61.3%) was greater than in controls (47.0%) and single BCC (52.2%), and the frequency of the combination GSTM1 null/male gender was significantly greater in patients with multiple tumours (P = 0.002). Frequency distributions of GSTM1 null/skin type 1 were also significantly different (P = 0.029) and the proportion of subjects who were GSTM1 null with skin type 1 was greater (P = 0.009) in the multiple BCC group. We examined the data for interactions between GSTM1 null/skin type 1/male gender by comparing frequency distributions of these factors in the single and multiple BCC groups. The distributions were almost significantly different (exact P = 0.051). No significant interactions between GSTT1 null or CYP2D6 EM and skin type 1 were identified. Comparisons of frequency distributions of smoking with the GSTM1 null, GSTT1 null and CYP2D6 EM genotypes identified no differences between patients with single and multiple tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554981      PMCID: PMC2074285          DOI: 10.1038/bjc.1996.8

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility.

Authors:  C R Wolf; C A Smith; A C Gough; J E Moss; K A Vallis; G Howard; F J Carey; K Mills; W McNee; J Carmichael
Journal:  Carcinogenesis       Date:  1992-06       Impact factor: 4.944

2.  Risk factors for basal cell carcinoma in a prospective cohort of women.

Authors:  D J Hunter; G A Colditz; M J Stampfer; B Rosner; W C Willett; F E Speizer
Journal:  Ann Epidemiol       Date:  1990-10       Impact factor: 3.797

3.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Authors:  J Seidegård; W R Vorachek; R W Pero; W R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  The validity and practicality of sun-reactive skin types I through VI.

Authors:  T B Fitzpatrick
Journal:  Arch Dermatol       Date:  1988-06

5.  Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus.

Authors:  A A Fryer; L Zhao; J Alldersea; W R Pearson; R C Strange
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  DNA repair related to multiple skin cancers and drug use.

Authors:  Q Wei; G M Matanoski; E R Farmer; M A Hedayati; L Grossman
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

7.  Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.

Authors:  K Nakachi; K Imai; S Hayashi; K Kawajiri
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

8.  Location of gene for Gorlin syndrome.

Authors:  P A Farndon; R G Del Mastro; D G Evans; M W Kilpatrick
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

9.  Identification of the primary gene defect at the cytochrome P450 CYP2D locus.

Authors:  A C Gough; J S Miles; N K Spurr; J E Moss; A Gaedigk; M Eichelbaum; C R Wolf
Journal:  Nature       Date:  1990-10-25       Impact factor: 49.962

10.  Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours.

Authors:  A H Heagerty; D Fitzgerald; A Smith; B Bowers; P Jones; A A Fryer; L Zhao; J Alldersea; R C Strange
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321

View more
  7 in total

1.  The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and -P1.

Authors:  Udo Vester; Birgitta Kranz; Stephanie Zimmermann; Rainer Büscher; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

2.  Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer.

Authors:  Zeyuan Lei; Ting Liu; Xiang Li; Xiaoxia Xu; Dongli Fan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients.

Authors:  J T Lear; B B Tan; A G Smith; W Bowers; P W Jones; A H Heagerty; R C Strange; A A Fryer
Journal:  J R Soc Med       Date:  1997-07       Impact factor: 5.344

4.  Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome.

Authors:  X R Yang; R M Pfeiffer; A M Goldstein
Journal:  J Med Genet       Date:  2006-04       Impact factor: 6.318

5.  Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis.

Authors:  Hao Peng; Quanyong He; Jie Zhu; Cheng Peng
Journal:  Tumour Biol       Date:  2012-11-27

6.  Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci.

Authors:  M Esteller; A García; J M Martínez-Palones; J Xercavins; J Reventós
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression.

Authors:  P Sarhanis; C Redman; C Perrett; K Brannigan; R N Clayton; P Hand; C Musgrove; V Suarez; P Jones; A A Fryer; W E Farrell; R C Strange
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.